Welcome to the Galveston National Lab
The Galveston National Laboratory (GNL) is a sophisticated high containment research facility that serves as a critically important resource in the global fight against infectious diseases. The GNL is located on the campus of the University of Texas Medical Branch and operates under the umbrella of UTMB’s Institute for Human Infections and Immunity.
The National Institute of Allergy and Infectious Diseases (NIAID) provides funding for the BSL4 laboratories and operations at the GNL, and the lab’s top priority is research to develop diagnostics, therapeutics and vaccines to combat emerging and re-emerging diseases that threaten public health, not only in our country, but around the world.
Researchers at the GNL are internationally known for their expertise working with pathogens including Ebola and Marburg and emerging infectious diseases like COVID-19 and MERS. Scientists not only research the pathogens (viruses) themselves, but they also study the vectors for disease threats: mosquitos, which carry and transmit West Nile, Zika, Malaria, Chikungunya and many other diseases, and ticks, which cause diseases that are of grave concern and top priority to the National Institutes of Health. In addition to basic research that aides understanding about transmission and pathogenesis of emerging viruses, GNL scientists are developing medical countermeasures for disease threats, including dangerous pathogens called Select Agents, which are high priority for study because of their high mortality rates, limited treatments and potential to be used as weapons around the world.
The Galveston National Laboratory is home to research that is funded by NIAID, the U.S. Department of Defense, the U.S. Centers for Disease Control & Prevention and other federal agencies, as well as academic partners, private foundations, and the Biopharmaceutical industry.